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Abstract
Background: In European countries, including Switzerland, cannabis is the most commonly used illicit drug. Offering a
Web-based self-help tool could potentially reach users who otherwise would not seek traditional help. However, such Web-based
self-help tools often suffer from low adherence.
Objective: Through adherence-focused guidance enhancements, the aim of this study was to increase adherence in cannabis
users entering a Web-based self-help tool to reduce their cannabis use and, in this way, augment its effectiveness.
Methods: This paper presents the protocol for a three-arm randomized controlled trial (RCT) to compare the effectiveness of
(1) an adherence-focused, guidance-enhanced, Web-based self-help intervention with social presence; (2) an adherence-focused,
guidance-enhanced, Web-based self-help intervention without social presence; and (3) a treatment-as-usual at reducing cannabis
use in problematic users. The two active interventions, each spanning 6 weeks, consist of modules designed to reduce cannabis
use and attenuate common mental disorder (CMD) symptoms, including depression, anxiety, and stress-related disorder symptoms
based on the approaches of motivational interviewing and cognitive behavioral therapy. With a target sample size of 528, data
will be collected at baseline, 6 weeks, and 3 months after baseline. The primary outcome measurement will be the number of
days of cannabis use on the preceding 7 days. Secondary outcomes will include the quantity of cannabis used in standardized
cannabis joints, the severity of cannabis dependence, changes in CMD symptoms, and adherence to the program. Data analysis
will follow the intention-to-treat principle and employ (generalized) linear mixed models.
Results: The project commenced in August 2016; recruitment is anticipated to end by December 2018. First results are expected
to be submitted for publication in summer 2019.
Conclusions: This study will provide detailed insights on if and how the effectiveness of a Web-based self-help intervention
aiming to reduce cannabis use in frequent cannabis users can be improved by theory-driven, adherence-focused guidance
enhancement.
Trial Registration: International Standard Randomized Controlled Trial Number Registry: ISRCTN11086185;
http://www.isrctn.com/ISRCTN11086185 (Archived by WebCite at http://www.webcitation.org/6wspbuQ1M)
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Introduction
Epidemiology
According to the European Drug Report 2016 [1], approximately
13% of Europeans in the age range of 15 and 34 years have
used cannabis in the last year; it is by far the most commonly
used illicit drug. Translated into absolute numbers, there are
approximately 16.6 million Europeans who use cannabis, with
roughly one percent of European adults estimated to use
cannabis daily [1]. Within Europe, Switzerland ranks third in
the national prevalence of cannabis use: the lifetime prevalence
rate of cannabis use is 27.9% (men 32.8%, women 23.2%),
whereas the 6-month prevalence rate is 5.4% (men 7.6%, women
3.3%). The highest prevalence is found in the age group between
15 and 24 years. Within this group, the 6-month prevalence rate
is 14.4%, with almost one-fifth of users using cannabis daily
[2].
Even though these numbers are high, only a minority of cannabis
users seem to develop cannabis dependence; in general
population surveys, the risk of becoming dependent on cannabis
appears to be between 10% and 11% among all cannabis users
[3,4]. However, within the subgroup of cannabis users who
started using cannabis in early life, the risks of cannabis
dependence [5] and cannabis use problems [6] are much higher.
Although cannabis dependence has not been shown to increase
mortality in the general population, its impact on the global
burden of disease should not be understated. Expressed in
disability-adjusted life years (DALYs), which is the sum of
years of life lost because of premature mortality and years lived
with disability, it has been estimated that, in 2010, cannabis
dependence accounted globally for approximately two million
DALYs [7].
Furthermore, poorer mental and physical health, lower
educational achievement, and decreased cognitive functioning
are all commonly seen in daily cannabis users [8]. Numerous
studies also point to the associations between a broad range of
primary mental illnesses and frequent cannabis use, highlighting
the potential for detrimental effects of co-occurring mental
health disorders on treatment in problematic cannabis users [9].
Patients who seek treatment for their cannabis use disorder at
Swiss outpatient addiction treatment centers are mainly young
males in the age range of 15 and 24 years [10]. Data from the
monitoring system for addiction counseling and addiction
treatment in Switzerland suggest a linear increase in new patients
for whom cannabis is the main problem substance from 2004
(8.8%) to 2014 (46.7%) [11], a trend that has also been observed
in other European countries [1]. However, it is clear that even
though the number of treatment seekers has steadily increased,
they still represent the minority of problematic cannabis users
(eg, scoring 8 or higher on the Cannabis Use Disorder
Identification Test) [12] who could potentially profit from
treatment, among whom approximately half develop cannabis
dependence [5], and many suffer from comorbid mental health
problems [9].
Accessibility and Reachability
There are various possible reasons why the percentage of
problematic cannabis users who seek treatment is still so low.
First among them are problems with accessibility: as addiction
treatment centers are rare, low accessibility force potential
treatment seekers, especially those living in more rural areas,
to travel considerable distances. This increase in time required
for travel is especially a hindrance, given that most addiction
counseling centers operate during normal office hours, rendering
attendance for potential treatment seekers almost impossible if
they have a job that requires them to work during these hours
[10,13]. The second reason pertains to the issue of
stigmatization, with the fear of being stigmatized as a drug
addict likely preventing many problematic cannabis users from
seeking face-to-face treatment. As older individuals generally
have greater social responsibilities, it is quite possible that the
levels of fear increase as the age of users increase. Consistent
with this assumption, users of Web-based self-help tools for the
reduction of problematic cannabis use appear to be older and
use more cannabis than those who seek help at outpatient
addiction treatment centers [10].
Issues relating to self-efficacy also can be problematic, as some
users have the desire to quit or reduce their cannabis
consumption on their own [14]. Finally, many cannabis users
lack insight into the various problems potentially caused by
their cannabis use. For example, although many users are aware
of some side effects of problematic cannabis use, such as mild
depressive symptoms, the physical risks associated with the
combustion and inhalation of smoke are often overlooked. These
risks include heart disease, lung cancer, and chronic obstructive
pulmonary disease [15,16]. Frequent users are more prone to
disregard these risks than occasional users, but increased
awareness could be advantageous for all, as it has been shown
that the more users know about the possible physical risks of
problematic cannabis use, the greater their intention to quit or
at least reduce their cannabis use is [15,16].
Web-based self-help programs to reduce problematic substance
use, such as—in the case of cannabis—CANreduce, could be
a great asset in reaching those groups within the general
population who would otherwise not seek treatment. Such
programs facilitate access by being available around the clock
and easily reachable from any home that has a computer and
an Internet connection. Nowadays, many Web-based self-help
programs also work on mobile devices, making almost any
situation a potential treatment session. Apart from this huge
improvement in accessibility relative to regular bricks and
mortar treatment centers, Web-based programs also solve the
fear of stigmatization issue. Allowing for anonymity, as well
as enabling self-efficacy, it is often an ideal solution for at least
a subgroup of users. Apart from all this, these noninvasive tools
are low-cost and, depending on how they are set up (eg, whether
or not they have counselors on standby for chat sessions), require
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little maintenance effort, lowering the costs once developed to
just Web server space, domain name registration, minimal
administrative support, and the effort needed to regularly update
techniques and design. Naturally, this is of great interest amid
the current environment of constantly increasing health care
costs, as is the case in Switzerland and other industrialized
countries [17].
Previous Studies and Implications
However, all the aforementioned positive characteristics of such
Web-based self-help programs only hold true if they actually
are effective in their goal of reducing problematic cannabis
consumption. This has indeed been consistently shown for
programs aiming to reduce problematic alcohol use [18,19] and
also—albeit to a lesser extent and not as consistently—for
programs aiming for tobacco smoking cessation [20,21]. The
Web-based approach for the most commonly used illicit drug,
cannabis, has not been studied as thoroughly. To our knowledge,
only two Web-based self-help programs to reduce problematic
cannabis consumption have been tested for their effectiveness
in appropriate RCTs in adults [10,22].
“Reduce Your Use: How to Break the Cannabis Habit” is an
Australian self-help intervention that is fully automated and
consists of six modules which are—similar to
CANreduce—based on cognitive behavioral therapy (CBT),
motivational interviewing (MI), and behavioral
self-management. In an RCT, this intervention was shown to
be more effective at reducing the frequency and quantity of
cannabis consumption than a psychoeducational control
condition. Regarding adherence to the 6-week program,
two-thirds of the initial participants completed the intervention
[22].
In addition, a previous version of CANreduce has been
investigated with the objective of determining whether a
Web-based self-help tool for reducing problematic cannabis
consumption would be more effective if individualized chat
sessions with a professional coach are offered [13]. Although
the study found that participants who were in the group with
the opportunity for individual chat sessions reduced their
frequency of cannabis use more than those who only worked
with the self-help tool, the effect was also identified among
those in a chat sessions group who did not actually make use
of the chat offer (ie, who did not reply to chat-based consultation
appointments offered by professional chat counselors). Thus,
it appears that even just the option of having chat appointments
reduced cannabis consumption [10]. With only a quarter of
participants who were given the option of scheduling a chat
session actually taking advantage of the offer, the question was
raised as to whether the same effect could be recreated by
simpler means, eliminating the need for professional counselors
on constant standby.
With CANreduce 2.0, we try to address this problem by
implementing adherence-focused guidance, which has already
been documented to be effective at increasing adherence to
Web-based self-help relative to Web-based self-help alone
[23,24]. The concept of adherence-focused guidance is primarily
based on the supportive-accountability model of guidance in
Web-based interventions [25] that asserts that unguided self-help
programs are often less effective than those that are guided [26].
However, Mohr’s model for adherence to electronic health
(eHealth) interventions encompasses further factors, which we
additionally attempt to address, to strengthen the concepts of
accountability and legitimacy with the assumption of thereby
increasing the effectiveness of the support in terms of adherence.
Specifically, we emphasize the social presence factor and those
factors that increase program legitimacy as defined by Mohr’s
model [25].
Furthermore, almost two-thirds of CANreduce participants in
the former study screened positive for clinically relevant
depression symptoms at baseline [10]. Moreover, even if
partakers of intervention programs do not exhibit depressive
symptoms at baseline, it is possible that such symptoms could
emerge as they decrease their drug use. Comorbidity of
depressive symptoms and substance use and its hindrance on
positive treatment outcomes has been demonstrated several
times before [27]. Furthermore, targeting a reduction in
depressive symptoms in patients simultaneously could possibly
increase adherence to the program. Therefore, the new version
of CANreduce also aims to specifically target issues that
potentially help to ameliorate depression and other common
mental disorder (CMD) symptoms such as those associated with
anxiety and stress-related disorder using CBT [27] and teaching
social problem-solving skills [28]. Moreover, we incorporated
aspects within modules targeting excessive rumination and
worry, as well as difficulties with relaxing.
Study Aims
The study presented in this protocol seeks to investigate and
compare the effectiveness of Web-based self-help interventions
at reducing cannabis use in problematic users, while taking into
account the most frequently co-occurring mental health
symptoms. Moreover, it examines whether adherence to the
program can be optimized by emphasizing the social presence
factor of adherence-focused guidance, which would only
marginally increase costs versus guidance that is less personal.
Methods
Study Design
The Web-based self-help program CANreduce will be evaluated
within a three-arm RCT, comparing the effectiveness of an
adherence-focused, guidance-enhanced, Web-based self-help
intervention with a social presence; an adherence-focused,
guidance-enhanced, Web-based self-help intervention without
a social presence; and treatment-as-usual (TAU) at reducing
cannabis use in problematic users. The masking technique will
be partially single-blinded—in that participants in either of the
two active treatment groups will not know which version they
work with. The two versions are neutrally described as two
differently optimized variants to prevent participants from
having a preference of one over the other possibly resulting in
a disappointment when being allocated to the unwished version.
However, subjects will know whether they have been assigned
to TAU. Any blinding of research and study personnel is not
warranted. After successful completion of the baseline
assessment (t0), participants will be allocated to one of the three
study conditions. Further assessments will take place both 6
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weeks (t1) and 3 months (t2) after baseline (Figure 1). The trial
has been registered with the ISRCTN registry and is traceable
as ISRCTN11086185.
Recruitment of Study Participants
Recruitment will take place from August 2016 to December
2018 to ensure that the target sample size of 528 participants
has been included. Participants will be recruited through the
CANreduce website itself [29], which is already established
and has links to it on various Internet health portals.
Additionally, advertisements will be placed in relevant Internet
forums and newspapers (or Web-based versions thereof).
For compensation, all participants who complete 3 months of
follow-up from the start of the program will be able to choose
between an Web-based voucher worth 30 Euro or donating that
amount to charity.
Registration and Consent Procedure
Participants can register online and will need to provide only
minimal personal data, including their email addresses, phone
numbers (only to get in contact with if follow-up questionnaires
are not filled out), and some basic demographical data (age,
gender, and level of education).
Before registration, each participant will be informed online
about the study, specifically provided information about the
following:
1. Purpose, background, and an overview of the study
2. Inclusion and exclusion criteria (Tables 1 and 2)
3. The difference between the three treatment arms (but no
details about how the two active treatment arms differ) and
their one in three chance of being allocated to each one of
these three arms
4. Financial aspects (no participation fee, compensation for
participation)
5. Potential risks of participation and when to contact their
general practitioner or, alternatively, a professional they
can select from a medical advisory and emergency list that
will be accessible at all times merely by clicking on
emergency icon
6. The inability of CANreduce to replace face-to-face therapy
for problematic cannabis use or abuse
7. The voluntary nature of participation and their right to
withdraw from the study at any time without consequences,
except for the loss of further compensation
8. Confidentiality and data protection (anonymity is ensured
by not recording real names or postal addresses and by
deleting email addresses and phone numbers before
statistical analysis and data archiving)
9. The approval given by the ethics committee of the Canton
Zurich after the committee had reviewed the study
Informed consent will be accepted once participants have
activated several check boxes restating important study points
and have submitted their consent by clicking a submission
button.
Randomization and Trial Flow
Once participants have completed their baseline assessment,
they will be randomized by a computer algorithm in a 1:1:1
ratio into one of three parallel groups, and this assignment will
be registered automatically in the background database.
Figure 1. Trial flowchart.
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Table 1. Inclusion criteria and underlying rationale.
ReasoningInclusion criteria
To ensure knowledge of procedures and the declaration of consentInformed consent via the Web form
To ensure a minimum age of participationMinimal age of 18 years
To include participants with less than daily cannabis use, increase validityCannabis use at least once weekly over the last 30 days
To ensure at least some access to the interventionAt least once weekly Internet access and a valid email address
To ensure that participants will be able to understand the information
provided
Good command of the German language
Table 2. Exclusion criteria and underlying rationale.
ReasoningExclusion criteria
To avoid confounding treatment effectsParticipation in other psychosocial or pharmacological treatments for the
reduction or cessation of cannabis use
To avoid having subjects with these problems enter the studyCurrent pharmacologically treated psychiatric disease or any history of
psychosis, schizophrenia, bipolar type I disorder, or significant current
suicidal or homicidal thoughts
As participants assigned to TAU will immediately become aware
of this, we expect that some might try to circumvent their
assignment by registering another account, hoping to end up in
a different group. If anyone attempts this, he or she nevertheless
will be assigned to the original group when they try to register
again on the same day based upon his or her Internet protocol
address.
Participants will be introduced step by step into the
corresponding study arm and, in the cases of study arms 1 and
2, be invited to participate in the program. Participants assigned
to study arm 3 will be informed that they will be provided access
to the Web-based self-help treatment after 3 months (with TAU
until they are 3 months past their baseline assessment).
Participants in study arms 1 and 2 will receive automated email
notifications to log in and enter their cannabis consumption
quantity and frequency into their consumption diary every week.
The two experimental interventions will each last 6 weeks.
Follow-up assessments will be 6 weeks and 3 months after the
start of the program. As such, there will be a baseline
(pretreatment) assessment, a 6-week assessment immediately
following the treatment program, and a final assessment 6 weeks
posttreatment (3 months postbaseline).
The control condition will be TAU. As these subjects will have
access to any other online and offline drug counseling services
that are available, they will be asked about their possible use of
other treatment services over the course of observation at their
final follow-up visit.
Follow-up assessments should be completed online after a
reminder is sent by email, in which they also will be reminded
that, upon completion of the entire 3-month follow up
assessment, they will be compensated with 30 Euro (via either
an Web-based voucher or the choice to make an online charitable
donation). If the final assessment is not completed within 2
days, the same reminder will be sent out two more times, 2 days
apart. If these reminders still go unanswered, participants will
be contacted by phone within 1 week after the third email has
been sent and offered an interview on the phone with study
collaborators to complete the follow-up instruments. Should
participants still refuse, they will be asked to answer questions
about the primary outcomes only or—should they still refuse—to
provide a reason for refusing, which will then be documented.
It is not uncommon for participants of Web-based interventions
to take breaks, yet still complete the intervention later.
Therefore, there are no dropout criteria relating to inactivity.
The only dropout criterion is active withdrawal from the study
by the participant, in which case only the data already gathered
will be analyzed.
Figure 1 shows a flow chart depicting the flow of subjects
through the study.
Hypotheses
We will test the following detailed study hypotheses with respect
to the main outcome: reduction in the number of days of
cannabis use over the past week, comparing the baseline,
6-week, and 3-month follow-up assessments:
1. An adherence-focused, guidance-enhanced, Web-based
self-help program with a social presence (study arm 1) is
more effective than an adherence-focused,
guidance-enhanced, Web-based self-help program with no
social presence (study arm 2) at reducing cannabis use.
2. An adherence-focused, guidance-enhanced, Web-based
self-help program to reduce cannabis use with a social
presence (study arm 1) is more effective than TAU (study
arm 3) at reducing cannabis use.
3. An adherence-focused, guidance-enhanced, Web-based
self-help program to reduce cannabis use without a social
presence (study arm 2) is more effective than TAU (study
arm 3) at reducing cannabis use.
4. Participants in study arm 1 will demonstrate better
adherence than participants in study arm 2 over the 6-week
intervention.
We have similar expectations with respect to our secondary
cannabis-related outcomes and will explore frequently
co-occurring mental disorders as predictors of adherence and
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outcomes. Specifically, we also want to explore, for the first
time, the influence of attention deficit hyperactivity disorder
(ADHD) symptoms on adherence to and outcomes from a
Web-based intervention among problematic cannabis users.
Intervention
CANreduce is an automated Web-based self-help tool developed
by the Swiss Research Institute for Public Health and Addiction
(ISGF) and and the Arud Centre for Addiction Medicine to
reduce cannabis consumption in problematic cannabis users.
The Web-based self-help intervention consists of a dashboard,
a consumption diary, and eight modules designed to reduce
cannabis use based on the principles of MI, self-control
practices, and CBT methods. Participants can study all of the
modules at their own pace and in whatever order they choose,
though a specific order is advised.
As CANreduce 2.0 is regarded as a medical device because of
the European Union guidelines 93/42/EWG and 2007/47/EWG,
its conformity has been assessed, and potential risks have been
evaluated. It is now fully certified in European conformity.
Active Study Arms
The following elements of CANreduce will be used in both
active treatment arms in this study (study arms 1 and 2). The
social presence enhancements added just to the program offered
to study arm 1 subjects will be described in the social presence
section below.
Start Page
Before actual registration or log-in, a video is accessible in
which the scientific director of the ISGF gives a quick
introduction to CANreduce. This introduction can also be read
as text and aims to motivate eligible individuals to participate
in the study.
Dashboard
The dashboard (see Figure 2) serves as the central hub,
displaying useful information at a quick glance. On the
dashboard, participants can see the date when they started the
program and how many days remain for them in it. It also
displays the dates of the two follow-up assessments and indicates
when they have been completed. The same is true of the
individual intervention modules, and by clicking a link,
participants will be taken to the page in the module where they
left off the last time they logged in. There is also a way for
subjects to directly enter cannabis consumption data over the
preceding week, which then displays a consumption graph.
Figure 2. Dashboard for study arm 1 (translated from German to English for publication purposes only).
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Figure 3. Main menu (translated from German to English for publication purposes only).
Self-Help Intervention Modules
There are eight self-help intervention modules that are the same
for both active treatment groups in terms of the information
presented. They are depicted on intervention website’s main
menu page (see Figure 3), as well as on the dashboard.
Participants are encouraged to complete either one or two of
these modules each week and to complete all of the modules in
order, though they can access all modules right away. It is also
stated that they should feel free to jump directly to modules
they feel could be of importance at the moment and to repeat
any modules they feel they either especially need to take a
second look at, or that they perceive to be especially helpful
within the 6 weeks of the program.
A bar in the module overview will indicate the progress they
have made with each module; that bar is fully green when the
entire module is completed.
The eight modules are summarized in Table 3 and are described
below.
Module 1: Introduction
In this module, which is largely based on MI techniques, a
general overview of the program is given, and fictional
companions are introduced. Additionally, participants are
encouraged to state their personal reasons for and against their
cannabis consumption, which they can review at any time, so
they may reflect on what they could gain by successfully
completing the program.
Module 2: Identifying Risky Situations
Apart from identifying personal situations in which participants
could find it difficult to stand by their set consumption goals
and working through these scenarios so they are better prepared
when they arise, another focus of this module is on seemingly
irrelevant decisions and chains of events that can potentially
result in unplanned cannabis use. This is an area also explored
in traditional CBT.
Module 3: Working on Needs
In this module, participants learn skills to help them strengthen
their social contacts, decrease possible ruminations, and develop
healthier sleeping habits. The importance of sleep and its impact
on quality of life is explained. Participants are encouraged to
install some rules or rituals to improve their sleeping quality
(eg, no big meals or sports in the evening and taking time to
unwind the day). Rumination and its impact on well-being is
explained, and several techniques are presented to counteract
such behavior (eg, thought stop, an audio file with a passing
clouds meditation, or refocusing on positive things we are
grateful for). Finally, social contacts and their link with mood
are explained. Participants are encouraged to list people they
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wish to be in closer contact with, what they could do about it,
and what negative beliefs inhibit them from doing so.
Module 4: Craving
Here, the concept of craving is explained with its physical and
mental aspects for which participants are encouraged to state
examples from their own experience. The key concept of triggers
(conditioned stimuli) is explained and its link to risk situations,
making module 2 worth a suggested revisit. Five possible ways
to deal with craving are presented: distraction, talking about
craving, mindful experiencing of craving, envisioning negative
consequences of consumption, and self-talk.
Module 5: Dealing With Relapses
Temporary relapses can happen, but they should not decrease
a person’s motivation to achieve their personal consumption
goal or be cause for grievance. In this module, participants are
taught skills for relapse prevention and to not see relapses as
catastrophic events, but rather to learn from them and view their
consumption goals as a long-term process.
Module 6: Working on Problems
The relationships between cannabis consumption, problems in
life, and mild depressive symptoms are highlighted in module
6. Here, participants learn how to deal with problems that they
cannot personally affect and are shown problem-solving skills
to help them to deal with problems that are seemingly too large
to tackle.
Module 7: Saying “No”; Refusal Skills
In this module, different ways to strengthen refusal skills are
taught to decrease the person’s risk of a relapse whenever and
wherever they find themselves in high-risk situations.
Module 8: Preserving Achievements
In the eighth and final module, participants are encouraged to
review their work in the program and then generate a list of five
personalized points that can help them to secure their
achievements once their participation in the program is
completed.
Fictional Companions
Six fictional companions appear within the modules at key
points, with the goal of encouraging reflection on certain
questions raised by the modules. This is done by the companions
thinking out loud, sharing their thoughts on issues raised in
written form. Participants can choose one character that best
fits their own situation but can also click through the input
provided by the other five companions.
Consumption Diary
Participants are encouraged to fill out their cannabis
consumption diary completely on at least a weekly basis. They
can enter their goal about how much they want to use in
upcoming days and how much they actually did use in past days
in terms of the number of individually standardized joints.
This individual joint is defined at the start of the program where
participants can select between (1) indoor, outdoor, or resin;
(2) mixed with or without tobacco; and (3) six different amounts
of the substance varying from 67 mg to 500 mg depicted with
six photos of unrolled joints corresponding to the type selections
from (1) and (2).
Table 3. Overview of contents and therapeutic approaches in the modules.
Therapeutic approachContentsModule
Based on motivational interviewing (MI)
techniques [30]
Module 1: Introduction • General overview
• Introduction of fictional companions
• Reflection on personal cannabis consumption
Cognitive behavioral therapy (CBT) ap-
proach to relapse prevention [31]
Module 2 : Identifying risk situations • Identifying personal high-risk situations
• Recognizing seemingly irrelevant but triggering decisions
Behavioral activation approach [32]Module 3: Working on needs • Strengthening social contacts
• Decreasing excessive ruminations
• Developing healthier sleeping habits
Based on CBT [33]Module 4: Craving • Concept of craving
• Ways to deal with feelings of craving
CBT approach to relapse prevention [31]Module 5: Dealing with relapses • Relapse prevention
• Dealing with relapses
Social problem-solving approach [34]Module 6 : Working on problems • Relationships between consumption, problems, and de-
pressive symptoms
• Skills to deal with solvable and unsolvable problems
Based on CBT [33]Module 7: Saying "no"; refusal skills • Strengthening refusal skills for use in high-risk situations
Based on MI techniques [30]Module 8: Preserving achievements • Review of program
• List of five personalized points to help secure achieve-
ments after the program is complete
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Overall, there are 36 different photos made for this selection
procedure [10,13]. A graph is generated live with these data
inputs and provides the participant with visual feedback. The
ability to anonymously set daily consumption goals could
possibly counteract the self-deception often seen in face-to-face
drug counseling and strengthen the self-efficacy of users. By
adding this consumption diary to both active study arms, Mohr’s
accountability factor—goal setting—is also integrated into the
program.
Other Elements
The CANreduce tool further consists of a section with general
useful information regarding cannabis, such as physical risks
and harm reduction techniques. Furthermore, in some modules,
participants are asked to enter their answers to certain exercises
(either by clicking on checkboxes or entering text freely). These
data are accessible in the section My Contribution.
Automated Motivational Email Feedback
Each week, participants in intervention arms 1 and 2 will be
sent automated motivational email feedback that will contain a
reminder to fill out their consumption diary and a direct link to
the CANreduce log-in site. If participants do not fill out their
diary, they will receive a different reminder email 1 and 3 days
later.
Additional emails will be sent out, either automatically or
triggered by an administrator or moderator, if certain conditions
are met—for example, if an increase in a participant’s cannabis
consumption or stalling of consumption reduction is
detected—as well as encouraging emails to work with the
self-help tool if only a few modules have been completed after
2 and 4 weeks. These feedback emails will also include module
suggestions, depending on how subjects have responded in
exercises dealing with high-risk situations, cravings, or the pros
and cons of their consumption.
In the first CANreduce study [10], participants sometimes
discontinued their use of the Web-based self-help tool simply
because they had initially aimed for a minimal reduction in
consumption and reached this self-set goal within the first few
weeks. Therefore, depending on their goals entered into the
consumption diary, participants will receive a message
encouraging them to reduce their consumption by at least 20
percent over the first week and, if they succeed, to continue that
trend in subsequent weeks. Alternatively, participants who do
not succeed at reaching their goal will receive the suggestion
that they aim for a more modest goal and continue until their
final consumption goal is reached.
Another finding from the first version of CANreduce was that
some users seek not only to reduce their consumption, but to
become completely abstinent. When this goal was achieved
early in the program, some felt less inclined to continue with
the program. This will be addressed in this study with an
automated email, triggered when actual consumption is recorded
as zero for several days consecutively in a subject’s consumption
diary, encouraging them to nonetheless complete certain
modules of importance to their current situation (eg, preventing
and dealing with relapses).
One important component of adherence-focused guidance, as
defined by Ebert et al [24], is adherence monitoring. Through
these mostly automated emails, either encouraging participants
to work with the self-help tool or suggesting modules that they
have not yet completed, this will be implemented in both active
study arms. Another crucial element of adherence-focused
guidance is feedback on demand. This too has been implemented
in both active study arms by inviting participants at the end of
each email to send in any questions that might arise for them
during the course of the program. For subjects in the first study
arm, this option will also be displayed on the dashboard.
Although the content of these nonautomated answers is not
specific to either study arm, the format of the emails will differ
between study arm 1 and 2, as described next, under social
presence.
Social Presence
Certain specific enhancements have been implemented in study
arm 1 in accordance with points made in Mohr’s supportive
accountability model [25]. Added social presence aims to give
the self-help tool a personal feel, creating a form of alliance
between the user and the Web-based self-help tool by replicating
that aspect of human support. We aim to recreate rapport similar
to what typically is found in client-counselor relationships,
without the need to have such a counselor on constant standby.
It has been argued by Mohr et al [25] that adherence increases
when there is accountability to a coach, who should be seen as
trustworthy, benevolent, and having expertise. By introducing
a mostly automated eCoach named Deborah, we seek to quite
literally give our Web-based tool a face. Although difficult to
define one individual who implies the aforementioned attributes
to all potential users of the self-help tool, we sought out an
eCoach who appears visually friendly and supplemented the
representation of benevolence with video scripts and emailed
texts that suggest expertise, as well as trustworthiness (see
Figure 2).
We created short introduction videos for most of the modules,
in which Deborah greets the user, gives her opinion on the
importance of certain key points within the module, and finishes
by wishing the user an enjoyable time working on the module
and acknowledging that they will see each other again in the
next module. Additionally, a picture of the eCoach Deborah
will be constantly displayed on the dashboard.
She also will personally invite users to write to her should they
have any questions or problems. As in the chat version of the
first CANreduce study [10], we expect that the number of
participants who will actually take her up on this offer will be
relatively small. However, we also expect that the assurance
that they have the option to write to her will exert a positive
impact on their adherence and, thereby, increase their treatment
success. Emails written to the eCoach’s address will be answered
by available study collaborators—if needed after consultation
with a certified therapist; consequently, the answer that querying
subjects will receive will address whatever issue or issues they
have. In this way, however, the task of replying to emails can
be spread out among multiple persons, while retaining that
element of personal, one-on-one rapport. It is assumed that the
content of this feedback will not, in itself, enhance the
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effectiveness of the program, but that having the option for
direct contact with their own coach will enhance subjects’
perception of the coach’s benevolence and legitimacy.
Furthermore, automatic email reminders or module suggestions
will have a greater personal touch in the adherence-focused,
guidance-enhanced version with a social presence (Deborah)
than in the version without the social presence (no Deborah).
In such correspondence, the participants will be addressed by
their username; emails and other written communication from
the eCoach will be signed as “your eCoach Deborah”; and all
text will be written from a first-person perspective (eg, modules
will be recommended by her personally; see Textbox 1).
For technical reasons, only one eCoach has been introduced in
this newer version of CANreduce. If the demand for personal
feedback by the eCoach proves to be greater than expected,
replies will be written by multiple coaches. As it could be
perceived as deceitful if they all represented themselves as
Deborah, the coaches will each sign those emails as an associate
or representative of eCoach Deborah.
Therefore, although participants in both active study arms will
receive the same level of support, those in the second study arm
will be supported by an undisclosed entity, whereas the form
of support provided to those in the first study arm will appear
to be more intimate and more closely resembling face-to-face
coaching.
Control Conditions
The control condition will be TAU, as it cannot be ruled out
that participants who are allocated to the third study arm will
seek out other treatment options during the waiting period. At
the last follow-up assessment, participants will be asked if, over
the course of their 3 months in the study, they used other
treatments and what they were; these data will then be analyzed.
After 3 months of follow-up, these subjects’ study phase will
be finished, at which time they will be offered the opportunity
to start the self-help program if they so choose.
A second control condition pertains to the presence versus
absence of a social presence. As described above, there will be
two active control groups, one with and one without the eCoach
Deborah in their version of the self-help tool.
Technical Specifications
CANreduce 2.0 is based on the content management system
Drupal 7, with a MySQL database. It will be administered
internally by the information technology (IT) developer at the
institution where the principle investigator (PI) works as faculty.
All access will be administered via encrypted and
password-protected secure sockets layer connections to
canreduce.ch [29]. At any time, any participant will have access
to his or her own data only. The administrator will have full
access to all of the data from all subjects.
All data will be entered online by the users themselves. The
website ensures a certain degree of data validation, such as
accepting only numbers for number fields, ensuring that users
do not mark multiple choices for single choice questions,
insisting that certain mandatory fields are filled out, and so on.
Textbox 1. Module suggestion on the basis of open text answers for pros and cons for the keywords difficulty with falling asleep, tiredness, social
inhibition, feelings of guilt, blaming oneself, and rumination.
With social presence:
Hello [participant’s user name]!
You have been using the program for some time now and have already completed a few of the modules. Well done!
If I may, I’d like to make a recommendation. I looked at your pros and cons of using cannabis and want to point out
module 3 “Working on needs.“
This module covers three important topics: better sleep, less rumination, and social contacts. Perhaps one of these
topics will be particularly helpful in your current situation.
Why don’t you have a look at it this evening?
For questions or difficulties, feel free to contact me.
Best regards,
Your eCoach, Deborah
Without social presence:
Hello,
You have been using the program for some time now and have already completed a few of the modules. Well done!
On the basis of your pros and cons of using cannabis, module 3 “Working on needs” would be recommendable.
This module covers three important topics: better sleep, less rumination, and social contacts. Perhaps one of the
topics would be particularly helpful in your current situation.
Why don’t you have a look at it this evening?
For questions, you can write to canreduce@canreduce.ch.
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Table 4. Assessment instruments.
3-month follow-up (t2)Week 6 (t1)Initial assessment (t0)Assessment instruments
XSociodemographics
XXCenter for Epidemiologic Studies Depression Scale
XXShort Screening Scale for DSM-IVa posttraumatic stress disorder
XXGeneral anxiety disorder-7
XXAdult ADHDb Self-Report Scale-version 1.1
XXXQuantity of cannabis use
XXXFrequency of cannabis use
XXXCannabis Use Disorder Identification Test-Revised
XXXSeverity of Dependence Scale
XXXFragebogen Substanzanamnese
XClient Satisfaction Questionnaire-I
XIntervention adherencec
XWAI-TECHd
XNegative effects according to Rozental
aDSM-IV: Diagnostic and Statistical Manual of Mental Disorders, 4th edition.
bADHD: attention deficit hyperactivity disorder.
cContinuous assessment during 6 weeks.
dWAI-TECH: Working Alliance Inventory adapted for Web-based interventions.
CANreduce also features a responsive design and can
automatically adapt to small screen devices such as tablets and
mobile phones. Users can register online by choosing a username
and providing a valid email address. To complete the registration
process, users will have to click on a verification link sent to
the email address specified, which will allow them to create a
personal password, while preventing anyone from registering
without a valid email address.
All data will be stored on a Web space hosted by an external
provider that meets the IT security outsourcing regulations
(99/2) of the Swiss Federal Banking Commission. Employees
of the Web host will need to identify themselves with biometric
data to gain physical access to the infrastructure.
Data will be extracted from the running Web-based database
via Drupal and PHPmyAdmin. The data will then be stored at
the PI’s institution on local computers for further processing
and local file servers for archiving.
Each subject’s email address and phone number will be deleted
after their participation in the study is complete and thereby,
not available for either current or future analysis.
The investigator affirms and upholds the principle of every
participant's right to privacy and that all personnel involved in
the study will comply with applicable privacy laws. No
individual data will ever be published or presented at scientific
meetings.
Measurements
Table 4 provides an overview of measurements.
Sociodemographic data will include subject gender, age, and
level of education.
The primary outcome of interest will be the number of days of
cannabis use on the preceding 7 days according to the
Time-Line-Follow-Back method [35,36].
Secondary outcomes of interest will include the quantity of
cannabis used in the previous week, in standardized cannabis
joints (as indicated in the consumption diary as well, as per
Schaub et al [10]). Participants can choose between three
different cannabis forms presented in photographs and in the
second step between five different standard joints for each
category (1/10 g, 1/6 g, 1/4 g, 1/3 g, and 1/2 g content pictures).
These joints are either pure cannabis or cannabis mixed with
tobacco. Finally, every participant has his or her personal
standard tobacco cigarette, a ruler with centimeter and millimeter
scales, the fraction amount in grams, and an open 10 cm paper
prepared to roll a joint and containing the cannabis plant- or
resin-tobacco mixture or pure cannabis presented in his or her
consumption diary. Further secondary outcomes are the presence
and severity of a cannabis use disorder (Cannabis Use Disorder
Identification Test-Revised, CUDIT-R); the severity of cannabis
dependence (Severity of Dependence Scale, SDS); the use of
alcohol, tobacco, or other illicit drugs besides cannabis
(Fragebogen Substanzanamnese, FDA); changes in depression,
anxiety, and attention deficit symptoms (Center for
Epidemiologic Studies Depression Scale, CES-D; general
anxiety disorder-7, GAD-7; and Adult ADHD Self-Report
Scale-V1.1, ASRS-V1.1); the Short Screening Scale for
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Diagnostic and Statistical Manual of Mental Disorders, 4th
edition (DSM-IV) posttraumatic stress disorder (PTSD); client
satisfaction (Client Satisfaction Questionnaire adapted to
Internet-based interventions, CSQ-I); and treatment adherence.
The perceived relationship between the user and the eCoach
will be assessed at the end of the program using the Working
Alliance Inventory [37] adapted for Web-based interventions
(WAI-TECH).
The CUDIT-R is a questionnaire containing eight items designed
to identify problematic cannabis consumption. Each item is a
statement regarding cannabis use, to which respondents are
provided with five response options, numbered from 0 to 4, that
vary between questions, but for which increasing scores indicate
increasing use or cannabis-related problems. As such, possible
scores range from a minimum of 0 to a maximum of 32. A score
of 8 or more indicates hazardous cannabis use, whereas a score
of 12 or more indicates a possible cannabis use disorder [12].
The SDS is a reliable and valid 5-item screening scale, with a
score of 4 or more being indicative of cannabis dependence
[38].
The FDA asks about a person’s years of lifetime consumption,
the past month’s consumption, and the manner of consumption
for the DSM-IV or the International Statistical Classification
of Diseases and Related Health Problems, 10th revision
substances of abuse. This measure was derived from the
EuropeASI, the European version of the Addiction Severity
Index [39].
The CES-D Scale is a short self-report scale designed to measure
depression symptoms in the general population [40]. All items
on the scale are symptoms associated with depression that have
been used in previously validated longer scales. CES-D
responses rate the frequency at which depression symptoms
have occurred over the past week. Possible scores on the
CES-D-20 range between 0 and 60, where a CES-D-20 cutoff
score of 16 is considered indicative of significant or mild
depression symptoms. This is equivalent to experiencing six
symptoms for most of the previous week or a majority of
symptoms on 1 or 2 days. Higher scores indicate a higher
symptom load.
The GAD-7 is a 7-item, self-report questionnaire to screen for
and estimate the severity of GAD and has good reliability as
well as factorial and concurrent validity [41]. These items ask
about nervousness, inability to stop worrying, excessive worry,
restlessness, difficulty relaxing, easy irritation, and the fear of
something awful happening. Total scores range from 0 to 21,
with a recommended cutoff score of 10 or higher.
The six-item short version of the ASRS-V1.1 can be
self-administered easily and quickly [42]. With a total possible
score of 24 and a cutoff score of 14, this six-item version has
been shown to have strong concordance with clinician diagnoses,
while significantly shorter than the full 18-item version.
The short screening scale for DSM-IV PTSD is designed to
assess for a lifetime history of PTSD [43]. A score of 4 or more
on the seven-symptom screening scale suggests PTSD.
The CSQ-I has been shown to be a suitable measure from the
user’s perspective in the evaluation of Web-based health
interventions. It is scored easily by summing up the individual
item scores to produce a score ranging from 8 to 32, with higher
scores indicating greater satisfaction [44].
Furthermore, the occurrence of any negative effects will be
identified, as in Rozental et al, at the 3-month follow-up
assessment [45].
Finally, we will ask all participants if they had used any other
treatment than canreduce.ch during the 3 months and if so, to
select from a predefined list of services.
As an indicator of treatment adherence, data will be collected
on which modules have been completed by the participant and
the number of weeks the consumption diary was filled out.
Additionally, a script has been implemented that allows us to
measure the time that subjects spend on each page. To avoid
false data that might result if a participant leaves a Web page
open but switches to a different window or leaves the computer,
a cutoff time of 10 min inactivity has been set, after which the
time spent on the page is disregarded and not saved to the
database. These data could potentially lead to insights into how
and specifically where to optimize CANreduce to further
decrease attrition rates. We also will assess the number of
individual emails received by each participant.
Sample Size Calculation
Anticipating that a Cohen d of 0.30 based on our previous study
experiences will be realistic for the effect size differences
between the unenhanced version of the Web-based tool and the
adherence-focused guidance-enhanced version, a sample size
of n=176 in each study group would have 80% power to detect
this difference based on calculations performed with G*Power
software (Faul, Kiel) with an alpha error of 5% and two-tailed
testing. Thus, we aim to recruit a total of 528 participants.
Data Analyses
Data will be analyzed according to the intention-to-treat
principle (ITT). To address missing data for the ITT analyses,
we will apply multiple imputation procedures with the package
Amelia in R (R Foundation for Statistical Computing, Vienna).
Amelia uses a bootstrapping-based algorithm that gives
essentially the same answers as the standard imputation posterior
or expectation maximum approaches according to the authors.
We plan to use between 20 and 40 imputed datasets depending
on the amount of missing data according to suggestions by
Graham [46]. The imputation model will include all primary
and secondary outcome variables. Auxiliary variables such as
demographic data may be included if they improve convergence
of the imputation model.
Differences between study arms in primary and secondary
continuous outcome variables at baseline and the follow-up
points will be tested using linear mixed models (LMM). LMMs
will be specified appropriately to model clusters and repeated
measures by defining random effects for study arms and time
(repeated measures). For nonnormal continuous outcomes,
appropriate distributions (eg, negative binomial and
zero-inflated) will be specified. For binary outcomes, a
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generalized linear mixed model (GLMM) will be specified that
defines an appropriate link-function. In the GLMM fixed effect,
coefficients will be interpreted in the context of the
subject-specific (nonmarginal) model fit.
Safety
Potential risks are expected to be minimal as no drugs will be
administered and the medical device (ie, the self-help tool) was
determined to be of very low risk during the course of its
European conformity certification. What we expect to observe
is some mild withdrawal symptoms such as craving, mild
depressive states, and sleep problems. These issues will be
addressed in the psycho-educational modules that are part of
the 6-week self-help intervention. At all times, an instant help
Web page will be available with instructions on what subjects
can do if their situation becomes unbearable. These instructions
contain psycho-educational self-help instructions, as well as
phone numbers to professional health care providers.
Results
The study will be conducted in accordance with the ethics
board–approved protocol and the principles stated in the current
version of the Declaration of Helsinki; the CONSORT eHealth
Guidelines [47] for studies on medical devices; the European
Directive on medical devices 93/42/EEC; and the ISO Norm
14155 and ISO 14971 as well as Swiss Law and Swiss
Regulatory Authority requirements. The local ethics committee
and regulatory authorities will receive annual safety and interim
reports and be informed about study termination, in agreement
with local requirements.
The study was approved by the ethics committee of the Canton
of Zurich on July 4, 2016 (BASEC-Nr. 2016-00264) and is
registered at Current Controlled Trials, traceable as
ISRCTN11086185.
Results will be published in a scientific peer-reviewed journal.
Anonymized study data will be available on request. Participants
will be informed via email about study results via a
lay-person-friendly summary of trial findings, if they have
requested so at registration.
Discussion
Principal Findings
To the best of our knowledge, this study will be the first to
assess the effectiveness—in terms of increasing adherence and
treatment success—of adding a social presence to
adherence-focused guidance by implementing a human element,
in accordance with the supportive accountability model [25],
all within the context of a Web-based self-help intervention
program to reduce problematic cannabis consumption. The
results of this RCT could add valuable insights into how to
increase adherence to Web-based self-help tools, for which high
attrition rates are one of the greatest reported problems. If users
do not adhere to the created content, treatment success is
unlikely. If these relatively simple techniques are shown to
increase adherence, these ideas could be extrapolated further
and easily applied to both current and future Web-based
self-help tools to aid in reducing problematic substance use of
any kind.
Although it must be noted that participants in the first
CANreduce study who received at least one chat session still
performed better than those in the same treatment condition
who did not [10], the offer of being able to contact an eCoach
who is perceived as benevolent, trustworthy, and having
expertise by email, with any questions or problems, might
adequately reproduce this beneficial effect.
Although adherence and treatment success have already been
shown to be greater in interventions in which participants have
the option of speaking with a therapist [10], the complexity and
costs are increased as well, as such sessions need to be
scheduled, and therapists must be available. Such increases in
cost and complexity should not be a problem with the human
element that we will be implementing, as it is a one-time effort
to shoot the videos and prewrite emails with a personal feel.
We expect that these features alone will increase program
effectiveness; and furthermore, that very few actual emails will
be sent by subjects seeking answers. If more emails than
anticipated need to be answered individually, this task could be
handled by multiple people to address less complex issues.
Meanwhile, the email format itself should leave enough time
for us to gather input from experts to address more complex
questions.
To explore the possible effects of the added content addressing
CMDs, we will compare outcomes against the study that
examined the first version of CANreduce. Another avenue for
exploration will be measuring adherence with specific modules
that address CMDs.
Limitations
The following protocol limitations must be considered:
First, cannabis users who are currently receiving other treatments
to reduce their cannabis consumption will be excluded.
However, CANreduce was designed to access cannabis users
who—for personal or practical reasons—would not attend
traditional addiction counseling. Second, all measurements will
be self-reported. Third, most of the self-report instruments we
will be using have not been validated in a Web-based context,
though they have largely been validated in other research and
clinical settings. Fourth, as found in the previous Web-based
intervention [10,22], we expect rather high rates of dropouts.
Finally, another possible limitation of Web-based studies is the
potential for low adherence rate because of the distant nature
of intervention.
Conclusions
This study will evaluate the effectiveness of an enhanced version
of CANreduce, a Web-based self-help intervention to reduce
problematic cannabis consumption. If shown effective, the
importance of CANreduce as a tool by which to reach users in
the general population who otherwise would not seek out
traditional mental health care, and addiction counseling services
will be documented.
The benefits of the intervention include providing cannabis
users with a better understanding of their addictive behaviors,
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teaching them psychological tools to handle drug cravings and
prevent relapses, and, ultimately, helping them to become free
of cannabis dependence.
Furthermore, if adding a social presence to adherence-focused
guidance augments the program’s effectiveness, valuable
insights could be gained into how to more effectively design
Web-based interventions. These findings could then be adapted
to other Web-based self-help tools, which present poor
adherence and high attrition rates.
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